Radiant Biotherapeutics to Present Next-Generation Multabody™ Approach for Cancer Immunotherapy at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting
TORONTO — Radiant Biotherapeutics, a biotechnology company committed to advancing a breakthrough antibody approach, the Multabody™, to treat cancer, autoimmune and infectious diseases, today announced the Company will present data on its Multabody™ approach a
(Financial Post, 2025-10-03T13:08:48Z)